StockData
UNITED THERAPEUTICS Corp logo

UNITED THERAPEUTICS Corp (UTHR) stock

UTHRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/3025% above fair value
$591.17−2.14 (-0.36%)

Close on Nov 13, 2026Market cap $25.36BP/E 22.3Yield –

United Therapeutics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

United Therapeutics's profit margin for the twelve months ending Sep 30, 2026 was 38.6%. For fiscal 2025 it was 41.9%, against 41.5% the year before. The highest annual figure on record is 42.3% in fiscal 2023.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202541.9%+0.4
FY2024Dec 31, 202441.5%−0.8
FY2023Dec 31, 202342.3%+4.8
FY2022Dec 31, 202237.6%+9.3
FY2021Dec 31, 202128.2%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 202631.1%−11.3
Q2 FY2026Jun 30, 202642.5%+3.8
Q1 FY2026Mar 31, 202635.2%−5.4
Q4 FY2025Dec 31, 202546.1%+5.2
Q3 FY2025Sep 30, 202542.4%+1.1
Q2 FY2025Jun 30, 202538.8%−0.1
Q1 FY2025Mar 31, 202540.6%−4.7
Q4 FY2024Dec 31, 202440.9%+5.6
Q3 FY2024Sep 30, 202441.3%−2.6
Q2 FY2024Jun 30, 202438.9%−4.6
Q1 FY2024Mar 31, 202445.2%−2.3
Q4 FY2023Dec 31, 202335.3%+8.4
Q3 FY2023Sep 30, 202343.9%−2.5
Q2 FY2023Jun 30, 202343.5%+18.6
Q1 FY2023Mar 31, 202347.5%−4.4
Q4 FY2022Dec 31, 202226.9%−0.1
Q3 FY2022Sep 30, 202246.4%+9.8
Q2 FY2022Jun 30, 202224.8%−13.8
Q1 FY2022Mar 31, 202251.9%+44.5
Q4 FY2021Dec 31, 202127.0%−18.0
Q3 FY2021Sep 30, 202136.6%+7.0
Q2 FY2021Jun 30, 202138.7%+0.0
Q1 FY2021Mar 31, 20217.5%−25.5
Q3 FY2020Sep 30, 202045.0%−9.9
Q2 FY2020Jun 30, 202029.6%–
Q1 FY2020Mar 31, 202038.6%–
Q3 FY2019Sep 30, 201933.0%–
Q2 FY2019Jun 30, 201954.9%–

More United Therapeutics figures

See a number that looks wrong?